Swaminathan Iyer, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, shares some of his highlights in T-cell lymphoma (TCL) from this year's EHA meeting, commenting on a TRBC1-targeting CAR-T therapy for TCL, as well as preclinical studies highlighting the importance of targeting macrophages. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
